l-carnitine supplementation to reverse hyperammonemia Reversible weakness and encephalopathy while on long-term valproate treatment due carnitine deficiency Frontiers | Carnitine and Depression
Description
Meijide S, Prez-Ruiz I, Hernndez ML, Navarro R, Ferrando M, Larreategui Z, et al
These delivery systems utilize the properties including the size, surface chemistry, and tunable functions which are inherent to nanoparticles and which overcome the drawbacks of traditional antioxidant treatments
About this article Cite this article Bahadoran, Z
The genes egt1 and egt2 from Schizosaccharomyces pombe were first introduced into C
